NU SKIN ENTERPRISES INC - A
NUSNYSETrading Snapshot
- Day Range
- $4.68 β $4.80
- 52-Week Range
- $4.45 β $11.67
- Volume (shares)
- 22,955
- Avg Volume (shares)
- β
- Shares Outstanding
- 48.7M
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- $1.49B
- Last Q Revenue
- $320M
- P/E Ratio
- β
- P/S Ratio
- 0.2x
- EPS (TTM)
- $-4.48
- Dividend Yield
- 5.07%
- Dilution (1yr)
- +0.4%
NU SKIN ENTERPRISES INC - A
NUSAbout NU SKIN ENTERPRISES INC - A
Nu Skin Enterprises, Inc. (NUS) is a global enterprise dedicated to the creation and worldwide distribution of beauty and wellness solutions. The company's diverse product offerings encompass advanced skincare systems, such as the ageLOC Spa and ageLOC Transformation age-defying lines, innovative devices like the ageLOC LumiSpa for comprehensive skin treatment and cleansing, and the ageLOC Boost, alongside various other cosmetic and personal care items. In the realm of health and nutrition, Nu Skin provides a comprehensive array of dietary and weight management products. This includes ageLOC Youth, LifePak, and ageLOC Meta nutritional supplements, in addition to ageLOC TR90 programs designed for weight control and body contouring, Beauty Focus Collagen+ skin care supplements, and other related weight management aids. The organization also significantly invests in research and development, particularly for its skincare and nutritional supplement portfolios. Nu Skin operates a network of retail stores and customer service centers exclusively within Mainland China. Its extensive product lines are marketed under its proprietary brands, which include Nu Skin, Pharmanex, and ageLOC. These products reach consumers through multiple sales channels, including direct-to-consumer interactions, an extensive network of independent distributors, and its dedicated e-commerce platform. Nu Skin Enterprises, Inc. was established in 1984 and maintains its corporate headquarters in Provo, Utah.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates
News unavailable.